Argo Blockchain Plc SEC Filings

Argo Blockchain plc (NASDAQ: ARBK) filed a Form 6-K containing a U.K. TR-1 “Notification of Major Holdings.” The filing discloses that J.P. Morgan Securities LLC crossed a reporting threshold on 8 July 2025 and now holds an aggregate 6.34 % of Argo’s voting rights, equal to 36,590,032 votes.

The position is split between:

• 228,052 ordinary shares (0.40 % voting rights)
• 34,309,000 American Depositary Receipts (5.94 % voting rights) classified as financial instruments under DTR 5.3.1R (1)(a)
• 780 votes (0.0001 %) via an equity swap expiring 30 May 2028

The previous TR-1 (not dated in this filing) showed a total holding of 8.27 %. Therefore, J.P. Morgan reduced its economic exposure by roughly 1.93 percentage points, primarily by trimming its derivative-based ADR position (from 7.87 % to 5.94 %). Because the stake remains above the 5 % U.K. notification threshold, the institution remains a significant shareholder.

No operational, earnings or strategic updates were included. The disclosure is limited to the shareholding change and is signed by CEO Justin Nolan on 11 July 2025.

Argo Blockchain plc has filed a Form 6-K to disclose a UK TR-1 notification of major holdings. The filing states that J.P. Morgan Securities LLC crossed a reportable threshold on 3 July 2025 and now controls 8.266788 % of Argo’s voting rights, equivalent to 47,712,252 voting rights.

The stake is split between 0.395084 % held directly in ordinary shares (2,280,252 shares) and 7.871704 % held via American Depositary Receipts (45,432,000 ADR-linked voting rights). The previous disclosure showed a combined 7.827392 %, indicating a modest increase of roughly 0.44 percentage points.

This report fulfils the UK Financial Conduct Authority’s DTR 5 transparency requirements and contains no operational, financial-performance, or earnings data. While the holding remains below 10 %, the increased institutional position by a large global broker may signal incremental confidence in Argo Blockchain’s equity.

Carnival Corporation & plc (NYSE: CCL, CUK) filed an 8-K to disclose the closing of a €1.0 billion (about US$1.1 billion) private offering of 4.125% senior unsecured notes due 2031. The notes were issued on 7 July 2025 under a new indenture and are guaranteed on a senior unsecured basis by Carnival Corporation and certain subsidiaries.

Use of proceeds: management will fully repay Carnival Corporation’s first-priority senior secured term loan maturing in 2027 and partially repay the similar facility maturing in 2028. The transaction therefore replaces nearer-term secured borrowings with unsecured debt that matures three to four years later, effectively terming-out €1 billion of obligations and releasing pledged collateral.

Key terms:

• Maturity: 15 July 2031.
• Coupon: 4.125%, paid annually starting 15 July 2026.
• Optional redemption: make-whole call to 14 Apr 2031; par call thereafter.
• Change-of-control put at 101% of principal.
• Covenants restrict liens, mergers and asset transfers; customary events of default apply.

Strategic implications: The refinancing extends the weighted-average maturity of Carnival’s debt stack, converts secured obligations to unsecured, and modestly diversifies the currency mix toward euros. While overall leverage is unchanged, unsecured issuance may lower the company’s blended cost of capital if the repaid term loans carried higher spreads. The covenant package provides incremental flexibility relative to first-lien debt.

The notes were placed with qualified institutional buyers under Rule 144A/Reg S and are not registered under the Securities Act. A press release announcing completion of the offering (Exhibit 99.1) was simultaneously furnished under Item 7.01 and is deemed "furnished" rather than "filed" for Exchange Act purposes.

Argo Blockchain plc (LSE: ARB; NASDAQ: ARBK) released a Form 6-K detailing the voting results of its adjourned Annual General Meeting held on 1 July 2025. Shareholders approved all ten ordinary resolutions, including acceptance of the FY-2024 Annual Report, the Directors’ Remuneration Report and Policy, re-election of three directors, and the re-appointment and remuneration of auditors. Ordinary resolutions passed with support ranging from 58.0 % to 96.2 %, but several attracted meaningful opposition, notably:

• Directors’ Remuneration Policy – 35.3 % against
• Re-appointment of Maria Perrella – 36.7 % against
• Re-appointment of Raghav Chopra – 32.8 % against
• Authorities to allot shares – c. 42 % against on both resolutions 9 and 10

Special resolution 13, permitting the Company to call general meetings on 14-day notice, was passed with 92.7 % support. However, special resolutions 11 and 12, which sought general and additional authority to disapply pre-emption rights, failed to reach the 75 % super-majority (support c. 63 % and 61 % respectively). Their rejection restricts the Board’s flexibility to issue equity without first offering shares to existing holders, potentially complicating any near-term capital-raising plans.

Overall voter turnout was low at ~4 % of issued share capital. In line with the QCA Corporate Governance Code, Argo acknowledged the significant dissent on several items and committed to engage with shareholders and provide an update “in due course.” No financial performance data or new strategic initiatives were disclosed in this filing.

Tucows Inc. (TCX) – Form 144 Insider Sale Notice

Chief Executive Officer Elliot Noss has filed a Form 144 indicating his intent to sell 12,937 common shares on or about July 1, 2025 through broker 3Macs, a division of Raymond James. Based on the filing’s stated aggregate market value of US$254,988, the planned sale price is approximately $19.70 per share. Tucows’ current shares outstanding are 11,057,112, so the proposed transaction represents roughly 0.12 % of total shares.

The Form 144 also discloses that Noss has already sold 14,900 shares over the past three months in 18 separate transactions, generating gross proceeds of roughly US$248,650. Combining past sales with the upcoming disposition brings total insider sales to 27,837 shares (about 0.25 % of shares outstanding) within a four-month window.

• Nature of shares: Common stock originally acquired on 17-Mar-2014 via a stock-option exchange.
• Broker: 3Macs (Raymond James), Toronto.
• Exchange: NASDAQ or TSX, per issuer dual-listing.

The filing is made under Rule 144, signaling that the seller asserts no undisclosed adverse information and is complying with holding-period and volume limitations. While the absolute number of shares is small relative to the float, continued insider selling—particularly by the CEO—can be perceived as a negative sentiment indicator by investors.

Argo Blockchain plc (NASDAQ: ARBK) has filed a Form 6-K to report the adjournment of its Annual General Meeting (AGM). The meeting, originally convened on 30 June 2025, could not proceed because a quorum was not present within the time specified in the Company’s articles of association. The AGM has been rescheduled for 08:30 BST on 1 July 2025 at the same venue (Fladgate LLP, 16 Great Queen Street, London).

Because of the adjournment, the AGM will not be streamed via the Investor Meet Company platform. Argo states that the voting results and any shareholder resolutions will be released to the market via RNS once the reconvened AGM concludes.

No financial results, operational updates, or transactional announcements accompany this notice. The disclosure is narrowly focused on the procedural delay and provides updated logistics and contact information for investor relations and the Company’s brokers.

Centessa Pharmaceuticals plc (CNTA) filed a Form 4 reporting the grant of an equity award to non-executive director Mathias Hukkelhoven. On 06/20/2025 the director received a share option covering 40,000 ordinary shares at an exercise price of $12.43 per share. The option vests in full on the earlier of the first anniversary of the grant or the company’s next annual shareholder meeting, contingent upon continued board service. The option expires on 06/20/2035. Following the grant, the reporting person beneficially owns 40,000 derivative securities (options) and no change was reported in non-derivative share ownership. Ordinary shares may be represented by ADSs on Nasdaq, each currently equal to one ordinary share.

The filing is a routine director compensation disclosure and does not indicate open-market buying or selling of CNTA shares. The transaction increases potential future dilution by less than 0.1% of the company’s outstanding shares, a level generally viewed as immaterial for valuation purposes.